Rod S Taylor

Generating author description...

All published works

Action	Title	Year	Authors
+	Combining tumour response and progression free survival as surrogate endpoints for overall survival in advanced colorectal cancer	2020	Eleni G. Elia Nicolas Städler Oriana Ciani R Taylor Sylwia Bujkiewicz
+	Use of surrogate endpoints in healthcare policy : proposal for consistent adoption of a validation framework	2016	Oriana Ciani Marc Buyse M Drummond Guido Rasi Everardo D. Saad Rod S Taylor
+ PDF Chat	Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study	2013	Oriana Ciani Marc Buyse Ruth Garside Toby Pavey Ken Stein Jonathan A C Sterne R Taylor

Common Coauthors

Coauthor	Papers Together
Oriana Ciani	3
Marc Buyse	2
Ken Stein	1
Jonathan A C Sterne	1
Sylwia Bujkiewicz	1
Toby Pavey	1
Ruth Garside	1
Guido Rasi	1
Nicolas Städler	1
Everardo D. Saad	1
M Drummond	1
Eleni G. Elia	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Surrogate End Points in Clinical Trials: Are We Being Misled?	1996	Thomas R. Fleming	2
+	Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema.	2007	Marissa Lassere Kent Johnson Maarten Boers Peter Tugwell Peter Brooks Lee S. Simon Vibeke Strand Philip G. Conaghan Mikkel Østergaard Walter P. Maksymowych	1
+	The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints	2007	Marissa Lassere	1
+	LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE)	2008	Kent Johnson Nick Freemantle Danielle Anthony Marissa Lassere	1
+ PDF Chat	Inconsistent reporting of surrogate outcomes in randomised clinical trials: cohort study	2010	Jeppe Lerche la Cour Jesper Brok Peter C Gøtzsche	1
+	Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials	1995	Klaus‐Peter Schulz	1
+	Surrogate threshold effect: an alternative measure for meta‐analytic surrogate endpoint validation	2006	Tomasz Burzykowski Marc Buyse	1
+	A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints	2005	Roger Harbord Matthias Egger Jonathan A C Sterne	1
+	Publication and related bias in meta-analysis	2000	Jonathan A C Sterne David J. Gavaghan Matthias Egger	1
+ PDF Chat	Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials	2007	Ignacio Ferreira‐González Gaiet Permanyer-Miralda Antònia Domingo‐Salvany Jason W. Busse Diane Heels‐Ansdell Víctor M. Montori Elie A. Akl Dianne Bryant Pablo Alonso‐Coello Jordi Alonso	1
+	The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials	2001	David Moher Kenneth F. Schulz Douglas G. Altman	1
+ PDF Chat	Estimating within‐study covariances in multivariate meta‐analysis with multiple outcomes	2012	Yinghui Wei Julian P. T. Higgins	1
+	Meta-analysis for the evaluation of potential surrogate markers	1997	Michael J. Daniels Michael D. Hughes	1
+	Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study	2011	Agnès Dechartres Isabelle Boutron Ludovic Trinquart Pierre Charles Philippe Ravaud	1
+	Clinical Trials: A Practical Approach.	1984	Ira Hill Stuart J. Pocock	1
+ PDF Chat	Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points	2001	Tomasz Burzykowski Geert Molenberghs Marc Buyse Helena Geys Didier Renard	1
+	<b>R2WinBUGS</b>: A Package for Running<b>WinBUGS</b>from<i>R</i>	2005	Sibylle Sturtz Uwe Ligges Andrew Gelman	1
+	The Evaluation of Surrogate Endpoints	2006	Hans C. van Houwelingen	1
+ PDF Chat	Bayesian Adaptive Trial Design for a Newly Validated Surrogate Endpoint	2011	Lindsay A. Renfro Bradley P. Carlin Daniel J. Sargent	1
+ PDF Chat	Multivariate meta‐analysis of mixed outcomes: a Bayesian approach	2013	Sylwia Bujkiewicz John R. Thompson Alex J. Sutton Nicola J. Cooper Mark Harrison Deborah Symmons Keith R. Abrams	1
+ PDF Chat	The validation of surrogate endpoints in meta-analyses of randomized experiments	2000	Marc Buyse Geert Molenberghs Tomasz Burzykowski Didier Renard Helena Geys	1
+ PDF Chat	Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints	2015	Sylwia Bujkiewicz John R. Thompson Enti Spata Keith R. Abrams	1
+ PDF Chat	Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer	2015	Oriana Ciani Marc Buyse Ruth Garside Jaime Peters Everardo D. Saad Ken Stein Rod S Taylor	1
+ PDF Chat	Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process	2015	Sylwia Bujkiewicz John R. Thompson Richard D. Riley Keith R. Abrams	1
+	Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ research	2002	Jonathan A C Sterne Peter Jüni Kenneth F. Schulz Douglas G. Altman Christopher Bartlett Matthias Egger	1
+	Inconsistent Reporting of Surrogate Outcomes in Randomised Clinical Trials: Cohort Study	2011	Courtney M. Smalley	1
+	The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials	2001	David Moher	1
+	Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study	2011	Peter Herbison Jean Hay‐Smith William J. Gillespie	1
+ PDF Chat	Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study	2008	Lesley J. Wood Matthias Egger Lise Lotte Gluud Kenneth F. Schulz Peter Jüni Douglas G. Altman Christian Gluud Richard M. Martin Anthony J G Wood Jonathan A C Sterne	1
+	Bayesian adjusted <i>R</i><sup>2</sup> for the meta‐analytic evaluation of surrogate time‐to‐event endpoints in clinical trials	2011	Lindsay A. Renfro Qian Shi Daniel J. Sargent Bradley P. Carlin	1
+ PDF Chat	Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences	2016	Danielle L. Burke Sylwia Bujkiewicz Richard D. Riley	1
+	Surrogate outcomes are associated with low methodological quality of studies of rheumatoid arthritis treated with antitumour necrosis factor agents: a systematic review	2011	Moacyr Roberto Cucê Nobre Frnanda Marques da Costa	1
+	A Bayesian hierarchical meta-analytic method for modelling surrogate relationships that vary across treatment classes	2019	Tasos Papanikos John R. Thompson Keith R. Abrams Nicolas Staedler Oriana Ciani Rod S Taylor Sylwia Bujkiewicz	1
+ PDF Chat	Bivariate network meta‐analysis for surrogate endpoint evaluation	2019	Sylwia Bujkiewicz Dan Jackson John R. Thompson Rebecca M. Turner Nicolas Städler Keith R. Abrams Ian R. White	1
+	None	2000	David J. Lunn Andrew C. Thomas Nicky Best David J. Spiegelhalter	1
+	Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework	2001	Arthur J. Atkinson Wayne A. Colburn Victor G. DeGruttola David L. DeMets Gregory J. Downing Daniel F. Hoth John A. Oates Carl C. Peck Robert T. Schooley Bert Spilker	1